Preconference course: Skin Cancer Epidemiology
Facilitated by the skin cancer research group of the Department of Dermatology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Thursday March 30th, 2017, 8.30-12.00
| 8.30-9.15 | (Routine) data used in skin cancer epidemiology.
(e.g. cancer registry data, cohort studies) Dr Marlies Wakkee |
| 9.15-10.00 | Basics of statistics in skin cancer epidemiology.
(e.g. standardization of incidence rates, trend analysis using joinpoint regression) Dr. Loes Hollestein |
| 10.00-10.25 | Break |
| 10.25-11.10 | Survival analysis I: the basics.
(e.g. kaplan-meier, competing risks) Dr Loes Hollestein |
| 11.10-11.55 | Survival analysis II: recurrent events of skin cancer.
(e.g. time-varying analysis of covariates) Dr Joris Verkouteren |
Meeting program
|
Thursday, March 30th, 2017
|
|
| 12:00PM – 12:15PM | Welcome |
| 12:15PM – 1:15PM | “Is causality restricted to interventions?” Prof Olaf Dekkers. Leiden University Medical Center (LUMC), Leiden, The Netherlands |
| 1:15PM – 2:30PM | Lunch |
| 2:30PM – 3:30PM | Group discussion of electronic posters |
| 3:30PM – 4:30PM | “Epidemiology, outcomes research and quality indicators: using epidemiology to improve quality of clinical care” Dr. Loreto Carmona. Research Director, Instituto de Salud Musculoesqueletica, Madrid, Spain |
| 4:30PM – 4:45PM | Break |
| 4:45PM – 6:45PM | Oral presentations |
| 4:45-4:55 | 25-hydroxyvitamin D and features of skin aging: a bidirectional Mendelian Randomization Study. Hamer MA1, Noordam R, Pardo LM, van Heemst D, Gunn DA, Nijsten T; 1 Erasmus MC University Medical Center |
| 5:00-5:10 | A Systematic Review of Photodynamic Therapy in Facial Photodamage. Sanclemente G1, Ruiz-Cañas V, Miranda JM, Ferrín AP, Ramirez PA, Hernandez GN; 1 Universidad de Antioquia |
| 5:15-5:25 | Registration of non-melanoma skin cancer in England – the tip of an iceberg? Venables ZC 1, Harwood C, Proby C, Leigh IM, Rashbass J ; 1 Public Health England |
| 5:30-5:40 | Development and validation of the Basal and Squamous cell carcinoma Quality of Life (BaSQoL) questionnaire. Waalboer-Spuij R1, Hollestein LM, Timman R, van de Poll-Franse LV , Nijsten T; 1 Erasmus MC University Medical Center. |
| 5:45-5:55 | Risk of incident cancer in psoriasis patients treated with biologics. Meta-analysis of nested case-control studies in Psonet registries. Garcia-Doval I 1, Descalzo MA, Mason K,Ormerod A, Griffiths C, Cohen AD, Ali H, Gomez-Garcia FJ, Herrera E, Cazzaniga S, Feldhamer I, Naldi L; 1 Fundación Piel Sana AEDV . |
| 6:00-6:10 | Suicide and nonfatal self-harm risk in people with psoriasis: a population-based cohort study using linked primary care, hospitalisation and mortality records. Parisi R1, Webb RT, Kleyn CE, Griffiths CEM, Ashcroft DM; 1 University of Manchester. |
| 6:15-6:25 | Obesity and the risk of incident psoriasis: a population-based cohort study. Snekvik I1, Lund TI, Langan SM, Smith C, Heilmann E, Saunes M; 1 Norwegian University of Science and Technology. |
| 6:30-6:40 | Psoriasis is not associated with cognitive function impairment and brain MRI-correlates: The Rotterdam Study. Pezzolo E1, Mutlu U, Vernooij MW, Arfan M, Dowlatshahi EA, Gisondi P, Girolomoni G, Nijsten T, Wakkee M; 1 University of Verona. |
| 8:30PM – | Dinner |
|
Friday, March 31st, 2017
|
|
| 8:30AM – 9:30AM | Oral presentations |
| 8:30-8:40 | Socioeconomic inequalities in the prevalence of skin diseases in the general population of 5 European countries. Ofenloch R 1, Svensson A, Bruze M, Naldi L, Cazzaniga S, Elsner P, Goncalo M, Schuttelaar ML, Diepgen TL; 1 University Heidelberg. |
| 8:45-8:55 | Outpatient dermatological diagnosis in Spain: results from a national survey. Descalzo MA 1, Buendía-Eisman A, Arias-Santiago S, Gilaberte Y, Fernandez-Crehuet P, Husein-ElAmehd H, Viera-Ramírez A, Fernández-Peñas P, Taberner R, García-Doval I; 1 Fundacion Piel Sana AEDV. |
| 9:00-9:10 | Reporting quality of case reports in international dermatology journals. Miguel D 1, Gonzalez N, Illing T, Elsner P; 1 Jena University Hospital. |
| 9:15-9:25 | Is initiation of isotretinoin a trigger for suicide attempt? Design considerations. Dupuy A 1, Droitcourt C, Rault C, Nowak E, Le Nautout B, Happe A, Oger E; 1 PharmacoEpidémiologie des Produits de Santé / Angence Nationale de Sécurité du Médicament. |
| 9:30AM – 10:30AM | “Use of primary care databases in epidemiologic research” Dr. Luis Alberto García Rodríguez. Director, Centro Español de Investigación Farmacoepidemiológica, Madrid, Spain |
| 10:30AM – 11:00AM | Break |
| 11:00AM – 12:00PM | Oral presentations |
| 11:00-11:10 | Prevalence and risk factors of toxic contact dermatitis: a secondary data analysis. Apfelbacher C1, Tesch F, Schmitt J; 1 Technical University of Dresden. |
| 11:15-11:25 | Prevalence and determinants of seborrheic dermatitis in a middle-aged and elderly population: The Rotterdam Study. Sanders MGH 1, Pardo LM, Franco OH, Ginger RS, Nijsten T; 1 Erasmus MC University Medical Center. |
| 11:30-11:40 | Sociodemographic variations in the incidence of eczema in children, 1997-2015: A population-based cohort study in England. Ban L 1, Langan SM, Abuabara K, Thomas KS, Sultan AA, Sach T, McManus E, Santer M, Ratib S; 1University of Nottingham. |
| 11:45-11:55 | Domestic hard water exposure in infancy and subsequent risk of childhood atopic eczema. Jabbar-Lopez ZK1, Perkin MR, Logan K, Marrs T, Craven J, Greenblatt DT, Strachan D, Lack G, Peacock JL, Flohr C; 1 St John’s Institute of Dermatology. |
| 12:00 AM – 1:00 PM | Oral presentations |
| 12:00-12:10 | TREatment of ATopic dermatitis (TREAT) Registry Taskforce: an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries. Gerbens LAA1, Apfelbacher CJ, Boyce AE, Wall D,Barbarot S, de Booij RJ, Deleuran M,Middelkamp-Hup MA, Roberts A, Vestergaard C, Weidinger S, Irvine AD, Schmitt J, Williamson PR, Flohr C, Spuls PI ; 1 University of Amsterdam. |
| 12:15-12:25 | Quantification of risk factors for postherpetic neuralgia in herpes zoster patients. Forbes HJ1,Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Mansfield K, MinassianC, Langan SM; 1 London School of Hygiene and Tropical Medicine. |
| 12:30-12:40 | Partner Bereavement and Risk of Herpes Zoster: Results from Two Population-Based Case-Control Studies in Denmark and the UK. Schmidt SAJ1, Vestergaard M, Pedersen HS, Schønheyder HC; Thomas SL, Smeeth L, Mansfield KE, Sørensen HT, Forbes HJ, Langan SM; 1 Aarhus University Hospital. |
| 12:45-12:55 | Incidence rates of sexually transmitted infections in ‘high-risk’ men who have sex with men – a meta-analysis of trials and cohort studies on HIV pre-exposure prophylaxis. Werner RN, Dressler C, Nast A; 1 Charité – Universitätsmedizin Berlin. |
| 1:00PM – 2:15PM | Lunch |
| 2:15PM – 3:15PM | “Missing data: an overview of the problem and the solutions” Prof. James Carpenter . Professor of Medical Statistics and Programme Leader in Methodology, MRC Clinical Trials Unit, London School of Hygiene and Tropical Medicine, London, UK |
| 3:15PM – 3:30PM | The final word |
Posters
| Hydrochlorothiazide use and risk of non-melanoma skin cancer.
Sidsel Arnspang, David Gaist, Sigrun Alba Johannesdottir Schmidt, Lisbet Rosenkrantz Hölmich, Søren Friis and Anton Pottegård. Clinical Pharmacology and Pharmacy, Department of Public Health, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark. |
| Immediate post-Mohs micrographic surgery adverse events: A Spanish multicentre prospective cohort study (Regesmohs).
A Toll-Abelló, V Ruiz-Salas, JR Garcés, T Alonso-Alonso, MA Rodríguez-Prieto, E Eusebio Murillo, R Miñano, JL López-Estebaranz, O Sanmartín-Jiménez, C Guillén Barona, I Allende Markixana, A Alfaro Rubio, Y Delgado Jiménez, E Vargas Diez, L Barchino Ortiz, P Lázaro Ochaita, E Villarasa, C Ciudad Blanco, H Vázquez-Veiga, JL Artola Igarza, ML Alonso, I García-Doval, MA Descalzo, P Redondo Belló. Hospital del Mar, Barcelona and Research Unit. Fundación Piel Sana Academia Española de Dermatología y Venereología, Madrid, Spain. |
| New Statistics Regarding the Incidence of Gorlin Syndrome in the Pediatric Population.
Fariha T. Siddiqui, B.S.; James A. Solomon, M.D., Phd University of Central Florida College of Medicine; Ameriderm Research, USA. |
| Investigating eczema as a risk factor for cardiovascular disease outcomes in a UK adult population.
Richard Silverwood, Harriet Forbes, Katrina Abuabara Krishnan Bhaskaran, Morten Schmidt, Sigrún Alba Jóhannesdóttir Schmidt, Liam Smeeth, Sinead Langan. London School of Hygiene and Tropical Medicine, UK. |
| Positive association between atopic dermatitis, anxiety and depression in Danish adults, but no increased risk of in-patient psychiatric treatment or suicide.
Jacob P. Thyssen, Carsten R. Hamann, Allan Linneberg, Lone Skov , Gunnar H. Gislason, Jashin J. Wu, Alexander Egeberg. Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Denmark. |
| Is Eczema Related to Self Reported School Performance?
Linda Beckman, Åke Svensson & Laura von Kobyletzki. Karlstad University, dep. Public Health; Department of Dermatology Malmö, Lund University, Sweden. |
| Methotrexate versus azathioprine in patients with atopic dermatitis: two years follow up data.
Evelien Roekevisch, Mandy Elvira Schram, Mariska Maria Geertruida Leeflang, Marijke Willemijn Dorothée Brouwer, Louise Anna Andrea Gerbens, Jan Dositheus Bos, Phyllis Ira Spuls. Department of Dermatology, Academic Medical Center, Amsterdam, The Netherlands. |
| Effects of time and remembrance of patch test results on quality of life (QoL) after testing. Cross-sectional study analyzing QoL in hand eczema patients 1, 5 and 10 years after patch testing.
Wasim N. Jamil and Magnus Lindberg. School of Medical Sciences, Örebro University and Department of Dermatology, University hospital Örebro, Örebro, Sweden. |
| Validation of a visual aided questionnaire for the self-assessment of hidradenitits suppurativa.
Luigi Naldi, Simone Cazzaniga, Federico Patta, Laura Atzori. Centro Studi GISED – Bergamo (Italy), Dermatology Clinic – University of Cagliari, Italy. |
| Study of Human Leukocyte Antigen (HLA) in familial frontal fibrosing alopecia.
Mª Librada Porriño-Bustamante, Miguel Ángel López-Nevot, José Aneiros-Fernández, Elena García-Lora, María Antonia Martín-Casares, Mª Antonia Fernández-Pugnaire, Salvador Arias-Santiago. Dermatology Department. Hospital Universitario Sanitas La Zarzuela, Madrid, Spain |
| Association of psoriasis with intima-media thickness and inflammatory markers.
Antonio Martinez-Lopez, Gonzalo Blasco-Morente, Israel Perez-Lopez, Francisco Jose Navarro-Triviño, Paula Aguayo-Carreras, Salvador Arias-Santiago. Dermatology Unit. Complejo Hospitalario Universitario de Granada, Spain. |